NCT06366802 Cohort Construction and Prognostic Model Construction for Multiple Myeloma Status ACTIVE_NOT_RECRUITING Phase N/A
NCT06359509 Study of SYS6020 in BCMA-positive Multiple Myeloma Status NOT_YET_RECRUITING Phase EARLY_PHASE1
NCT06359067 A Real-World Study of Bispecific Antibodies in Multiple Myeloma Status COMPLETED Phase N/A
NCT06357754 Transgene Assay Testing Service of Tumor Samples From Patients Who Received a Bristol-Myers Squibb Manufactured Gene Modified Cell Therapy and Have a Qualifying Second Primary Malignancy Status RECRUITING Phase N/A
NCT06353022 Minimal Residual Disease-based Strategy With T-Cell Redirector After Treatment With Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone (D-VRd) in Newly Diagnosed Multiple Myeloma Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT06352866 Siltuximab for Cytokine Release Syndrome Prophylaxis Prior to tx w/ Teclistamab in RRMM Status WITHDRAWN Phase PHASE2
NCT06350994 Early Assessment of Cardiac Function After Treatment With CAR-T Cells Status RECRUITING Phase N/A
NCT06348147 Dara-RVd Induction for Newly Diagnosed Multiple Myeloma With Autologous Stem Cell Transplantation Status SUSPENDED Phase PHASE2
NCT06348108 Talquetamab in Combination With Iberdomide and Dexamethasone for Relapsed or Refractory Multiple Myeloma Status RECRUITING Phase PHASE1
NCT06340646 Washington University Participant Engagement and Cancer Genomic Sequencing Center (WU-PE-CGS) Status RECRUITING Phase NA
NCT06333509 Anti-GPRC5D CAR-T Cells (CT071) in Participants With RRMM or RRpPCL Status NOT_YET_RECRUITING Phase PHASE1/PHASE2
NCT06328699 Chaplain-Delivered Compassion Meditation to Improve Spiritual Care of Patients Receiving Stem Cell Transplantation Status ACTIVE_NOT_RECRUITING Phase NA
NCT06323447 Pivotal Study to Validate a Novel System to Non-Invasively Detect Severe Neutropenia Status NOT_YET_RECRUITING Phase N/A
NCT06322927 PatIent exPeRiences and prEFerence of trEatment foR Multiple Myeloma Status COMPLETED Phase N/A
NCT06314698 Narlumosbart Compared With Denosumab in Patients With Multiple Myeloma Bone Disease Status NOT_YET_RECRUITING Phase PHASE3
NCT06302699 Detecting Minimal Residual Diseases (MRD) and Monitoring Clonal Evolution Using Ultrasensitive Chromosomal Aberrations Detection (UCAD) in Multiple Myeloma Status RECRUITING Phase N/A
NCT06297226 Study of Arlocabtagene Autoleucel (BMS-986393) a GPRC5D-directed CAR T Cell Therapy in Adult Participants With Relapsed or Refractory Multiple Myeloma Status RECRUITING Phase PHASE2
NCT06296368 DISCOVERY: Evaluating a Decision Support Tool for Adults Seen in Hematology/Oncology Clinics Status RECRUITING Phase NA